查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
个性化医疗市场规模、份额和趋势分析报告：按产品（个性化营养/健康、个性化药物治疗）、地区、细分市场预测，2022-2030 年
市场调查报告书
商品编码
1170859

个性化医疗市场规模、份额和趋势分析报告：按产品（个性化营养/健康、个性化药物治疗）、地区、细分市场预测，2022-2030 年

Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Nutrition & Wellness, Personalized Medicine Therapeutics), By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

个性化医疗市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球个性化医疗市场预计将达到 9227.2 亿美元。 由于疾病发病率的增加和对新疗法的需求不断增长，该市场预计从 2022 年到 2030 年的复合年增长率为 6.95%。 大量的研究工作不断加强个性化医疗的新兴应用。 例如，2022 年 7 月，UMass Chan 医学院的研究人员将开发基于微生物学的个体化微生物，以帮助理解代谢波动，测量它们与个体基因组、饮食、微生物组和相关环境因素的关联，并开发出医学模型系统。

许多癌症病症通常是由潜在的基因错配引起的，发展到晚期可能会致命。 通过了解特定的基因组特征，可以有效、准确地治疗癌症病症。 例如，2020 年 5 月，Qiagen 发布了 QIAseq pancancer multimodal，能够对癌症受试者的基因组特征进行稳健分析，从而在精准医学中广泛应用于实体瘤和血红素恶性肿瘤的分析。

NGS 技术的进步和对人类基因组的广泛研究正在积极推动这个市场。 人们越来越关注利用 NGS 来推动潜在的个性化医疗结果，以治疗癌症和罕见遗传病。 例如，Illumina 已宣布将在巴黎举行的欧洲肿瘤学会 (ESMO) 年会上介绍几项肿瘤学研究的执行摘要。 Illumina 研究使用活组织检查的全面基因组分析来将受试者与潜在药物和免疫疗法相匹配，从而实现个性化的癌症治疗。

远程医疗以虚拟方式或通过电话提供临床建议，以提供更大的身体便利。 远程医疗变得越来越流行，尤其是自 COVID-19 大流行以来。 政府和研究机构正在努力加强个性化远程医疗的应用。 例如，2022 年 8 月，国家癌症研究所承诺在五年内提供 2300 万美元的赠款，以帮助在全国启动远程医疗研究中心 (TRACE)。 该计划由白宫癌症登月计划支持，其使命是利用健康差异来开发和推进癌症护理的远程医疗服务。

分子成像设备和医疗设备在个性化医疗的新进展中发挥着重要作用。 这些设备可以有效地利用个性化医疗来治疗各种类型的癌症。 例如，2022 年 6 月，GE Healthcare 宣布将推出前列腺癌诊断和监测，以利用精准医疗和治疗诊断学在癌症进展的早期阶段进行个性化前列腺癌治疗。镓68放射性同位素

随着新技术的进步以及联合研究和扩张等持续的行业努力，市场正处于增长阶段。 例如，2021 年 12 月，Biogen 和 Therapanacia 宣布了一项合作，重点是推进神经科学个性化医疗的数字健康。

个性化医疗市场报告亮点

市场的整体增长归因于对利用遗传水平对疾病的理解的新型治疗药物的不断增长的需求以及全球癌症和遗传疾病发病率的上升。

由于药物遗传学在生物製药开发中的广泛应用，个性化治疗领域有望在预测期内实现高速增长。 此外，由于全基因组测序成本的显着降低，预计基因组治疗领域在预测期内将显着增长。

北美在 2021 年占据了市场主导地位，原因是主要参与者的存在以及对新疗法开发的深入研究，以寻找治疗各种疾病的方法。

内容

第一章调查方法及范围

  • 调查范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 目的

第 2 章执行摘要

  • 个性化医疗市场：市场展望

第 3 章市场变量、趋势和范围

  • 市场趋势和前景
  • 趋势分析
    • 产品趋势
      • 个性化医疗诊断的趋势
      • 个性化医疗的治疗趋势
      • 个性化医疗的趋势
      • 个性化营养和健康的趋势
  • 市场细分和范围
  • 市场动态
    • 市场驱动因素分析
      • 人类基因组数据在临床研究中的实用性
      • 有针对性的个性化医疗保健
      • 推动个性化医疗研发的技术进步
      • 先进基因组编辑技术的出现
      • 新数据库对研究的实用性
    • 市场製约因素分析
      • 个人基因组数据的伦理问题和保护
      • 有限访问人类基因组数据和数据库
    • 机会分析
  • COVID-19 大流行对个性化医疗市场的影响
  • 2021 年产品渗透率和增长前景图
  • 商业环境分析
    • 个性化医疗市场 - SWOT 分析，按因素（政治与法律、经济与技术）
    • 波特的五力分析
  • 市场份额分析
    • 公司规模
    • 产品组合
    • 战略举措
  • 竞争格局
    • 战略框架
    • 市场参与分类
      • 新/新进入者
      • 成熟的参与者和领导者

第四章产品业务分析

  • 个性化医疗诊断
    • 基因检测
    • 直接面向消费者 (DTC) 的测试
    • 奥术实验室服务
    • 奥术实验室测试
  • 个性化医疗
    • 医药
    • 基因组医学
    • 医疗设备
  • 个性化医疗
    • 远程医疗
    • 健康信息技术
  • 个性化营养和健康
    • 零售营养
    • 补充和替代医学

第 5 章按区域划分的业务分析

    • 个性化医疗市场：2021 年和 2030 年各地区趋势分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
  • 拉丁美洲 (LATAM)
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第六章公司简介

  • 公司简介
    • GE Healthcare
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Illumina, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ASURAGEN, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Abbott
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Dako A/S
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Exact Sciences Corporation
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Cepheid, Inc.（Danaher Corporation）
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Decode Genetics, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • QIAGEN, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Exagen Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Precision Biologics
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Celera Diagnostics LLC
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Biogen
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Genelex（Invitae Corporation）
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • International Business Machines Corporation（IBM）
      • 公司简介
      • 产品基准
      • 战略举措
    • Genentech, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 23 andMe, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: 978-1-68038-443-7

Personalized Medicine Market Growth & Trends:

The global personalized medicine market size is expected to reach USD 922.72 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 6.95% from 2022 to 2030 owing to the increasing incidence of diseases and the rising demand for novel therapeutic drugs. The emerging applications of personalized medicine are consistently enhanced by immense research efforts. For instance, in July 2022, researchers at the UMass Chan Medical School developed a microorganism-based personalized medicine model system to aid the understanding of variation in metabolism to gauge the connection between an individual's genome, diet, microbiota, and associative environmental factors.

Most cancer conditions are usually caused by an underlying genetic discrepancy and can cause fatalities with progression. The cancer condition can be effectively and precisely treated by understanding specific genomic characteristics. For instance, in May 2020, Qiagen launched QIAseq pan-cancer multi-modal panel to enable robust analysis of genomic characteristics of cancer subjects to derive a broad spectrum of applications in precision medicine for the profiling of solid tumors and heme malignancies.

The market is positively driven by advancements in NGS technologies and extensive research on the human genome. There has been an increasing focus on utilizing NGS to derive personalized medicine outcomes that could potentially be used for the treatment of cancer and rare genetic disorders. For instance, Illumina declared that it will present its multiple oncology research abstracts at the European Society of Medical Oncology (ESMO) annual meeting in Paris. Their research enables personalized cancer care using comprehensive genomic profiling of biopsies to match subjects to the potential drugs and immunotherapies.

Telemedicine facilitates virtual or telephonic clinical advice to aid physical convenience. Telemedicine is increasingly trending, especially after the COVID-19 pandemic. Government and research institutes are taking substantial efforts to enhance the applications of personalized telemedicine. For instance, in August 2022, the National Cancer Institute declared a grant of USD 23 million for five years to aid the launch of Telehealth Research Centers of Excellence (TRACE) across the U.S. The program was launched with the support of the White House Cancer Moonshot to seek development and advancements in telehealth delivery for cancer care with a mission to leverage health equity.

Molecular imaging systems and medical devices are playing a primary role in emerging advancements in personalized medicine. They effectively leverage the applications of personalized medicine in the treatment of different types of cancers. For instance, in June 2022, GE Healthcare declared the release of high-end molecular imaging by using gallium-68 radioisotope for the diagnosis and monitoring of prostate cancer so as to leverage access to precision health and theranostics for personalized prostate cancer treatment at an early stage of cancer progression.

The market is in the growth phase due to emerging technological advancements along with consistent industrial efforts such as collaborations and expansions. For instance, in December 2021, Biogen Inc., and TheraPanacea declared that they have signed a collaboration that focuses on advancing digital health for personalized medicine in neuroscience.

Personalized Medicine Market Report Highlights:

  • The overall growth of the market is attributed to the rising need for novel therapeutic drugs coupled with leveraged genetic level understanding of diseases and the rising incidence of cancers and genetic disorders across the globe
  • The personalized medicine therapeutics segment is anticipated to witness high growth over the forecast period owing to the extensive usage of pharmacogenomics for developing biopharmaceuticals. Further, the genomic medicine therapeutics segment is anticipated to grow substantially during the forecast period owing to significantly lowered costs of whole-genome sequencing
  • North America dominated the market in 2021 due to the presence of key players and their intensive research for the development of novel therapies to find out curative solutions for various diseases

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Objectives
    • 1.6.1 Objective 1
    • 1.6.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Personalized Medicine Market: Market Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends & Outlook
  • 3.2 Trend Analysis
    • 3.2.1 Product Trends
      • 3.2.1.1 Personalized Medicine Diagnostics Trends
      • 3.2.1.2 Personalized Medicine Therapeutics Trends
      • 3.2.1.3 Personalized Medical Care Trends
      • 3.2.1.4 Personalized Nutrition & Wellness Trends
  • 3.3 Market Segmentation & Scope
  • 3.4 Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Utility of human genome data for clinical research
      • 3.4.1.1.1Targeted and personalized healthcare
      • 3.4.1.2 Technological advancements to facilitate R&D for Personalized Medicine
      • 3.4.1.2.1 Emergence of advanced genome editing techniques
      • 3.4.1.2.2 Utility of novel databases for research
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Ethical issues and protection of individual's genomic data
      • 3.4.2.2 Limited access to human genome data and databases
    • 3.4.3 Opportunity analysis
  • 3.5 Impact of COVID - 19 Pandemic on Personalized Medicine Market
  • 3.6 Penetration & Growth Prospect Mapping for Products, 2021
  • 3.7 Business Environment Analysis
    • 3.7.1 Personalized Medicine Market - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.7.2 Porter's Five Forces Analysis
  • 3.8 Market Share Analysis
    • 3.8.1 Company Size
    • 3.8.2 Product portfolio
    • 3.8.3 Strategic Initiatives
  • 3.9 Competitive Landscape
    • 3.9.1 Strategy Framework
    • 3.9.2 Market Participation Categorization
      • 3.9.2.1 New/ emerging entrants
      • 3.9.2.2 Mature players & leaders

Chapter 4 Product Business Analysis

  • 4.1 Personalized Medicine Diagnostics
    • 4.1.1 Global Personalized Medicine Diagnostics Market, 2018 - 2030 (USD Billion)
    • 4.1.2 Genetic Testing
      • 4.1.2.1 Global Personalized Medicine Market for Genetic Testing, 2018 - 2030 (USD Billion)
    • 4.1.3 Direct - To - Consumer (DTC) Testing
      • 4.1.3.1 Global Personalized Medicine Market for Direct - To - Consumer (DTC) Testing, 2018 - 2030 (USD Billion)
    • 4.1.4 Esoteric Lab Services
      • 4.1.4.1 Global Personalized Medicine Market for Esoteric Lab Services, 2018 - 2030 (USD Billion)
    • 4.1.5 Esoteric Lab Tests
      • 4.1.5.1 Global Personalized Medicine Market for Esoteric Lab Services, 2018 - 2030 (USD Billion)
  • 4.2 Personalized Medicine Therapeutics
    • 4.2.1 Global Personalized Medicine TherapeuticsMarket, 2018 - 2030 (USD Billion)
    • 4.2.2 Pharmaceuticals
      • 4.1.2.1 Global Personalized Therapeutics Market for Pharmaceuticals, 2018 - 2030 (USD Billion)
    • 4.1.3 Genomic Medicine
      • 4.1.3.1 Global Personalized Therapeutics Market for Genomic Medicine, 2018 - 2030 (USD Billion)
    • 4.1.4 Medical Devices
      • 4.1.4.1 Global Personalized TherapeuticsMarket for Medical Devices, 2018 - 2030 (USD Billion)
  • 4.3 Personalized Medical Care
    • 4.2.1 Global Personalized Medical CareMarket, 2018 - 2030 (USD Billion)
    • 4.2.2 Telemedicine
      • 4.1.2.1 Global Personalized Medical Care Market for Telemedicine, 2018 - 2030 (USD Billion)
    • 4.1.3 Health Information Technology
      • 4.1.3.1 Global Personalized Medical Care Market for Health Information Technology, 2018 - 2030 (USD Billion)
  • 4.3 Personalized Nutrition & Wellness
    • 4.2.1 Global Personalized Nutrition & WellnessMarket, 2018 - 2030 (USD Billion)
    • 4.2.2 Retail Nutrition
      • 4.1.2.1 Global Nutrition & Wellness Market for Retail Nutrition, 2018 - 2030 (USD Billion)
    • 4.1.3 Complementary & Alternative Medicine
      • 4.1.3.1 Global Nutrition & Wellness Market for Complementary & Alternative Medicine, 2018 - 2030 (USD Billion)

Chapter 5 Regional Business Analysis

      • 5.1Persoanlized Medicine Market: Regional Movement Analysis, 2021 & 2030
  • 5.2 North America
    • 5.2.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.2.3 Canada
      • 5.2.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.3 Europe
    • 5.3.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.2 Germany
      • 5.3.2.1 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.3 U.K.
      • 5.3.3.1 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.4 France
      • 5.3.4.1 France market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.5 Italy
      • 5.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.3.6 Spain
      • 5.3.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.2 Japan
      • 5.4.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.3 China
      • 5.4.3.1 China market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.4 India
      • 5.4.4.1 India market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.5 Australia
      • 5.4.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.4.6 South Korea
      • 5.4.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.5 Latin America (LATAM)
    • 5.5.1 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.5.3 Mexico
      • 5.5.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.5.4 Argentina
      • 5.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.6 Middle East and Africa (MEA)
    • 5.6.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.6.3 Saudi Arabia
      • 5.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
    • 5.6.4 UAE
      • 5.6.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 6 Company Profiles

  • 6.1 Company Profiles
    • 6.1.1 GE Healthcare
      • 6.1.1.1 Company Overview
      • 6.1.1.2 Financial Performance
      • 6.1.1.3 Product Benchmarking
      • 6.1.1.4 Strategic Initiatives
    • 6.1.2 Illumina, Inc.
      • 6.1.2.1 Company Overview
      • 6.1.2.2 Financial Performance
      • 6.1.2.3 Product Benchmarking
      • 6.1.2.4 Strategic Initiatives
    • 6.1.3 ASURAGEN, INC.
      • 6.1.3.1 Company Overview
      • 6.1.3.2 Financial Performance
      • 6.1.3.3 Product Benchmarking
      • 6.1.3.4 Strategic Initiatives
    • 6.1.4 Abbott
      • 6.1.4.1 Company Overview
      • 6.1.4.2 Financial Performance
      • 6.1.4.3 Product Benchmarking
      • 6.1.4.4 Strategic Initiatives
    • 6.1.5 Dako A/S
      • 6.1.5.1 Company Overview
      • 6.1.5.2 Financial Performance
      • 6.1.5.3 Product Benchmarking
      • 6.1.5.4 Strategic Initiatives
    • 6.1.6 Exact Sciences Corporation
      • 6.1.6.1 Company Overview
      • 6.1.6.1 Financial Performance
      • 6.1.6.2 Product Benchmarking
      • 6.1.6.3 Strategic Initiatives
    • 6.1.7 Cepheid, Inc. (Danaher Corporation)
      • 6.1.7.1 Company Overview
      • 6.1.7.2 Financial Performance
      • 6.1.7.3 Product Benchmarking
      • 6.1.7.4 Strategic Initiatives
    • 6.1.8 Decode Genetics, Inc.
      • 6.1.8.1 Company Overview
      • 6.1.8.2 Financial Performance
      • 6.1.8.3 Product Benchmarking
      • 6.1.8.4 Strategic Initiatives
    • 6.1.9 QIAGEN, Inc.
      • 6.1.9.1 Company Overview
      • 6.1.9.2 Financial Performance
      • 6.1.9.3 Product Benchmarking
      • 6.1.9.4 Strategic Initiatives
    • 6.1.10 Exagen Inc.
      • 6.1.10.1 Company Overview
      • 6.1.10.2 Financial Performance
      • 6.1.10.3 Product Benchmarking
      • 6.1.10.4 Strategic Initiatives
    • 6.1.11 Precision Biologics
      • 6.1.11.1 Company Overview
      • 6.1.11.2 Financial Performance
      • 6.1.11.3 Product Benchmarking
      • 6.1.11.4 Strategic Initiatives
    • 6.1.12 Celera Diagnostics LLC
      • 6.1.12.1 Company Overview
      • 6.1.12.2 Financial Performance
      • 6.1.12.3 Product Benchmarking
      • 6.1.12.4 Strategic Initiatives
    • 6.1.13 Biogen
      • 6.1.13.1 Company Overview
      • 6.1.13.2 Financial Performance
      • 6.1.13.3 Product Benchmarking
      • 6.1.13.4 Strategic Initiatives
    • 6.1.14 Genelex (Invitae Corporation)
      • 6.1.14.1 Company Overview
      • 6.1.14.2 Financial Performance
      • 6.1.14.3 Product Benchmarking
      • 6.1.14.4 Strategic Initiatives
    • 6.1.15 International Business Machines Corporation (IBM)
      • 6.1.15.1 Company Overview
      • 6.1.15.2 Product Benchmarking
      • 6.1.15.3 Strategic Initiatives
    • 6.1.16 Genentech, Inc.
      • 6.1.16.1 Company Overview
      • 6.1.16.2 Financial Performance
      • 6.1.16.3 Product Benchmarking
      • 6.1.16.4 Strategic Initiatives
    • 6.1.17 23 andMe, Inc.
      • 6.1.17.1 Company Overview
      • 6.1.17.2 Financial Performance
      • 6.1.17.3 Product Benchmarking
      • 6.1.17.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Incidence of Diseases
  • TABLE 4 Global Personalized Medicine Market, By Region, 2018 - 2030 (USD Billion)
  • TABLE 5 Global Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 6 North America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 7 North America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 8 U.S. Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 9 Canada Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 10 Europe Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 11 Europe Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 12 Germany Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 13 U.K. Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 14 France Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 15 Italy Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 16 Spain Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 17 Asia Pacific Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 18 Asia Pacific Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 19 Japan Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 20 China Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 21 India Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 22 South Korea Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 23 Australia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 24 Latin America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 25 Latin America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 26 Brazil Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 27 Mexico Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 28 Argentina Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 29 Middle East & Africa Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
  • TABLE 30 Middle East & Africa Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 31 Saudi Arabia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 32 South Africa Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
  • TABLE 33 UAE Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)

List of Figures

  • FIG. 1 Information Procurement
  • FIG. 2 Primary Research Pattern
  • FIG. 3 Market Research Approaches
  • FIG. 4 Value Chain - Based Sizing & Forecasting
  • FIG. 5 Market Formulation & Validation
  • FIG. 6 Personalized Medicine Market Segmentation
  • FIG. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 10 Penetration & Growth Prospect Mapping
  • FIG. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 12 Porter's Five Forces Analysis
  • FIG. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 14 Personalized Medicine Market: Product Key Takeaways
  • FIG. 15 Global Personalized Medicine Market, for Product, 2018 - 2030 (USD Billion)
  • FIG. 16 Global Personalized Medicine Market, for Diagnostics, 2018 - 2030 (USD Billion)
  • FIG. 17 Global Personalized Medicine Market, for Genetic Testing, 2018 - 2030 (USD Billion)
  • FIG. 18 Global Personalized Medicine Market, for Direct - To - Consumer (DTC) Testing, 2018 - 2030 (USD Billion)
  • FIG. 19 Global Personalized Medicine Market, for Esoteric Lab Services, 2018 - 2030 (USD Billion)
  • FIG. 20 Global Personalized Medicine Market, for Esoteric Lab Tests, 2018 - 2030 (USD Billion)
  • FIG. 21 Global Personalized Medicine Market, for Therapeutics, 2018 - 2030 (USD Billion)
  • FIG. 22 Global Personalized Medicine Market, for Pharmaceutical, 2018 - 2030 (USD Billion)
  • FIG. 23 Global Personalized Medicine Market, for Genomic Medicine, 2018 - 2030 (USD Billion)
  • FIG. 24 Global Personalized Medicine Market, for Medical Devices, 2018 - 2030 (USD Billion)
  • FIG. 25 Global Personalized Medicine Market, for Personalized Medical Care, 2018 - 2030 (USD Billion)
  • FIG. 26 Global Personalized Medicine Market, for Telemedicine, 2018 - 2030 (USD Billion)
  • FIG. 27 Global Personalized Medicine Market, for Health Information Technology, 2018 - 2030 (USD Billion)
  • FIG. 28 Global Personalized Medicine Market, for Personalized Nutrition & Wellness, 2018 - 2030 (USD Billion)
  • FIG. 29 Global Personalized Medicine Market, for Retail Nutrition, 2018 - 2030 (USD Billion)
  • FIG. 30 Global Personalized Medicine Market, for Complementary & Alternative Medicine, 2018 - 2030 (USD Billion)
  • FIG. 31 Regional Outlook, 2021 & 2030
  • FIG. 32 North America Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 33 U.S.Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 34 Canada Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 35 Europe Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 36 Germany Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 37 U.K. Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 38 France Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 39 Italy Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 40 Spain Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 41 Asia Pacific Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 42 Japan Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 43 China Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 44 India Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 45 Australia Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 46 South Korea Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 47 Latin America Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 48 Brazil Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 49 Mexico Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 50 Argentina Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 51 Middle East and Africa Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 52 South Africa Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 53 Saudi Arabia Personalized Medicine Market, 2018 - 2030 (USD Billion)
  • FIG. 54 UAE Personalized Medicine Market, 2018 - 2030 (USD Billion)